IR @ Nirma University
Keeping in tune the global developments we are creating an institutional repository using DSpace Software (Digital Library Software). We are archiving institutional knowledge like, faculty papers, theses, and dissertations in PDF format at DSpace. Students can access this digital information anywhere in the campus.
Please use this identifier to cite or link to this item:
http://10.1.7.192:80/jspui/handle/123456789/12032| Title: | Comprehensive coverage on anti-mycobacterial endeavour reported during 2022 |
| Authors: | Dhameliya, Tejas M. Vekariya, Drashtiben D. Patel, Heta Y. Patel, Janvi T. |
| Keywords: | Heterocyclic scaffolds Anti-TB activity M. tuberculosis MDR-TB Mycobacterium |
| Issue Date: | 2023 |
| Publisher: | Elsevier Masson SAS |
| Series/Report no.: | IPFP0514; |
| Abstract: | TB being one of the deadliest diseases and second most common infectious cause of deaths, poses the severe threat to global health. The extended duration of therapy owing to resistance and its upsurge in immunecompromised patients have been the driving force for the development of novel of anti-TB scaffolds. Recently, we have compiled the account of anti-mycobacterial scaffolds published during 2015–2020 and updated them in 2021. The present work involves the insights on the anti-mycobacterial scaffolds reported in 2022 with their mechanism of action, structure activity relationships, along with the key perceptions for the design of newer anti- TB agents for the broader interests of medicinal chemists. |
| URI: | http://10.1.7.192:80/jspui/handle/123456789/12032 |
| Appears in Collections: | Faculty Papers |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IPFP0514.pdf | IPFP0514 | 1.84 MB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.